Molly Henderson

Molly Henderson is a seasoned finance executive with extensive experience in the pharmaceuticals and biotech industries. Currently serving as the Chief Financial and Business Officer at Phathom Pharmaceuticals since April 2022 and as Chief Financial Officer at UroGen Pharma since October 2020, Henderson also holds a position as Board Member and Audit Committee Chair at Calliditas Therapeutics AB. Additional leadership roles include Executive Chairman at WUJU Foods, and previous positions as Chief Financial Officer at Advaxis, Inc. and Iovance Biotherapeutics, Inc. Henderson's career began at PwC, where a tenure as Audit Manager laid the foundation for a robust financial acumen. Henderson holds both a Master of Business Administration and a Bachelor's Degree in Accounting from the University at Buffalo.